tbuckley/cabot-search huggingface dataset:
PREDICTING MAJOR ADVERSE CARDIAC EVENTS WITH COX NEURAL NETWORKS: RESULTS FROM THE REFINE SPECT REGISTRY
Authors: Piotr Slomka, Julian Betancur, Yuka Otaki, Frederic Commandeur, Tali Sharir, Andrew Einstein, Matthews Fish, Terrence Ruddy, Philipp A. Kaufmann, Albert Sinusas, Edward Miller, Timothy Bateman, Sharmila Dorbala, Marcelo Di Carli, Marcio Diniz, Guido Germano, Damini Dey, Lee Cooper, Daniel Berman
Journal: Journal of the American College of Cardiology (2019)
Abstract 297: Old Drug New Tricks: Repurposing Auranofin for Acute Myocardial Infarction by Targeting Protein Tyrosine Phosphatase PTP-PEST
Authors: Chiu-Fen Yang, Yi-Yun Chen, Yu-Wen Liu, Jai P Singh, Chia-Wei Chang, Ching-Feng Cheng, Tzu-Ching Meng
Journal: Circulation Research (2018)

Rationale: Myocardial ischemia/reperfusion (I/R) injury is almost unavoidable since reperfusion is the only established treatment for acute myocardial infarction (AMI). To date there has no effective strategies available for reducing I/R injury. Objective: To elucidate the mechanisms underlying myocardial I/R injury and to develop new strategies for attenuating the damage it causes. Methods and Results: Using I/R-mice model created by ligation of left anterior descending (LAD) artery, we found increases in activity of protein tyrosine phosphatases (PTPs) in myocardium during I/R. Treating the I/R-mice with a pan-PTP inhibitor PVS (phenyl vinyl sulfone) attenuated I/R damage, suggesting PTPs activation to be harmful in I/R. Through analyzing myocardial RNAseq data, we showed PTPs that are abundantly expressed in the myocardium. By exposing cardiomyocytes ablated with specific endogenous PTPs to hypoxia/reoxygenation (H/R), we found a role that PTP-PEST (PTPn12) plays to promote cell death under H/R stress. Auranofin, a drug being used in clinical practice for treating rheumatoid arthritis, may target PTP-PEST thus suppressing its activity. We recapitulated the function of auranofin as a PTP-PEST inhibitor by in vitro studies, and then examined its effect on myocardial I/R injury. In the mice receiving auranofin before reperfusion, myocardial PTP activity was suppressed, leading to restored phosphorylation of PTP-PEST substrates, including ErbB-2 that maintains survival signaling of the heart. In line with the suppression of PTP-PEST activity, the auranofin-treated I/R-mice had smaller infarct size and better cardiac function. Conclusions: PTP-PEST contributes to part of the damages resulting from myocardial I/R. The PTP inhibitor auranofin, acting through the PTP-PEST-ErbB-2 signaling axis, reduces myocardial I/R injury. Based on the finding, auranofin could potentially be used in the development of treatments to manage I/R injury in patients with AMI.
REAL-LIFE EXPERIENCE OF TRASTUZUMAB USE AMONG 806 BREAST CANCER PATIENTS: ROLE OF ROUTINE SERIAL ECHOCARDIOGRAPHY FOR THE EVALUATION OF ASYMPTOMATIC VENTRICULAR DYSFUNCTION IN THE FIRST 6 MONTHS OF TRASTUZUMAB THERAPY
Authors: Carolina M.P.D. Carvalho Silva, Marcio Bittencourt, Marilia Santos, Cristina Bittar, Silvia Fonseca, Giovanni Pinto, Isabela Costa, Clara Figueiredo, Julio Siqueira, Marina Bond, Paulo Neto, Thalita Gonzalez, Laura Testa, Paulo Hoff, Roberto Kalil-Filho, Ludhmila Hajjar
Journal: Journal of the American College of Cardiology (2019)
MORPHO-FUNCTIONAL ECHOCARDIOGRAPHIC PARAMETERS AND CARDIORESPIRATORY FITNESS IN PATIENTS WITH MITRAL VALVE PROLAPSE AND SIGNIFICANT MITRAL REGURGITATION
Authors: James L. Gentry, Nishant Shah, Mohamed Khayata, Kyle Mandsager, Sneha Vakamudi, Milind Desai, Brian Griffin, Dermot Phelan
Journal: Journal of the American College of Cardiology (2019)
Abstract 261: Activation of the Thromboxane/Prostanoid Receptor Contributes to Elevated End-Diastolic Calcium in Cardiomyocytes and Cardiac Fibrosis Following Right Ventricular Pressure Overload
Authors: Erica J Carrier, Kyungsoo Kim, Natalie A Noll, Ines Macias-Perez, W. David Merryman, Bjorn C Knollmann, James D West
Journal: Circulation Research (2018)

Like its systemic counterpart, pulmonary arterial hypertension (PAH) results in remodeling and fibrosis of the right ventricle as it attempts to adapt to the increased pressure overload. This eventually leads to contractile dysfunction, and RV failure is the primary cause of death in PAH patients. The G protein-coupled thromboxane/prostanoid (TP) receptor is expressed in vascular smooth muscle and immune cells, and is upregulated in cardiomyocytes following PAH. Activation of the cardiac TP receptor increases cardiomyocyte intracellular calcium and can lead to arrhythmias. We previously reported that oral treatment with the TP receptor antagonist ifetroban prevents RV fibrosis in a mouse pressure overload model of PAH. Here, we investigate the effects of TP receptor activation on calcium handling in RV cardiomyocytes and explore treatment of established RV remodeling with ifetroban, compared with prevention. Fixed pressure overload of the RV via pulmonary arterial banding (PAB) caused an increase in contractility and resting (end-diastolic) intracellular calcium in individual cardiomyocytes after 3 weeks; this occurred in conjunction with RV dilation, fibrosis, and stiffness. Surprisingly, total calcium content of the sarcoplasmic reticulum was increased following PAB. Antagonism with ifetroban decreased formation of fibrosis in a time-dependent manner. However, treatment with antagonist following establishment of RV fibrosis still prevented the cardiomyocyte increase in end-diastolic calcium. This suggests a multi-factorial contribution of the TP receptor in the RV response to PAH. Further studies continue to analyze changes in calcium-dependent signaling, as well as the contribution of the cardiomyocyte TP receptor to both fibrosis and calcium handling.
ACCURACY OF CARDIOINSIGHT NONINVASIVE ELECTROCARDIOGRAPHIC IMAGING COMPARED WITH INVASIVE MAPPING FOR DETERMINING LOCATION OF VENTRICULAR ARRHYTHMIAS
Authors: Jose Ernesto Betancourt, Amit Noheria, Daniel Cooper, Geoffrey Orme, Sandeep Sodhi, Curtis Steyers, Phillip Cuculich
Journal: Journal of the American College of Cardiology (2019)
Inflammatory endotypes in COPD
Authors: Peter J. Barnes
Journal: Allergy (2019)

Abstract Chronic obstructive pulmonary disease (COPD) is a major global health problem that is poorly treated by current therapies as it has proved difficult to treat the underlying inflammation, which is largely corticosteroid‐resistant in most patients. Although rare genetic endotypes of COPD have been recognized, despite the clinical heterogeneity of COPD, it has proved difficult to identify distinct inflammatory endotypes. Most patients have increased neutrophils and macrophages in sputum, reflecting the increased secretion of neutrophil and monocyte chemotactic mediators in the lungs. However, some patients also have increased eosinophils in sputum and this may be reflected by increased blood eosinophils. Increased blood and sputum eosinophils are associated with more frequent exacerbations and predict a good response to corticosteroids in reducing and treating acute exacerbations. Eosinophilic COPD may represent an overlap with asthma but the mechanism of eosinophilia is uncertain as, although an increase in sputum IL‐5 has been detected, anti‐IL‐5 therapies are not effective in preventing exacerbations. More research is needed to link inflammatory endotypes to clinical manifestations and outcomes in COPD and in particular to predict response to precision medicines.
PERVESE PREMATURE VENTRICULAR BEATS-VENTRICULAR ECTOPIC ARRHYTHMOGENIC CARDIOMYOPATHY IN THE SETTING OF GENOTYPE POSITIVE R814W-SCN5A DE NOVO MUTATION
Authors: Julio Perez-Downes, Martin Cerda, Bashar Al-Turk, Patrisha Shelley, Michael Kaufmann
Journal: Journal of the American College of Cardiology (2019)
THYROTOXIC PERIODIC PARALYSIS CROSSES BOARDERS FROM MUSCLES TO THE HEART: A CASE OF HYPOKALEMIC VENTRICULAR TACHYCARDIA
Authors: Bader Abu Ghalyoun, Ibrahim Khaddash, Ismail Mourad, Dema Shamoon, Allarice Linaac, Satish Tiyyagura
Journal: Journal of the American College of Cardiology (2019)
PATIENTS WITH ACUTE CORONARY SYNDROME, ELEVATED ATHEROGENIC LIPOPROTEINS, AND PRIOR CORONARY ARTERY BYPASS GRAFTING DERIVE LARGE ABSOLUTE BENEFIT FROM ALIROCUMAB: INSIGHTS FROM THE ODYSSEY OUTCOMES TRIAL
Authors: Shaun G. Goodman, Philip Aylward, Michael Szarek, Vakhtang Chumburidze, Deepak L. Bhatt, Vera Bittner, Rafael Diaz, Jay Edelberg, Corinne Hanotin, Robert A. Harrington, Johan Wouter Jukema, Sasko Kedev, Angele Moryusef, Robert Pordy, Gabriel Arturo Ramos López, Matthew T. Roe, Margus Viigimaa, Harvey D. White, Andreas M. Zeiher, Philippe Gabriel Steg, Gregory G. Schwartz
Journal: Journal of the American College of Cardiology (2019)
EARLY CARDIOVASCULAR MORTALITY FOLLOWING LIVER TRANSPLANTATION: TEMPORAL TRENDS FROM THE AUSTRALIAN &amp; NEW ZEALAND LIVER TRANSPLANT REGISTRY
Authors: Anoop Ninan Koshy, H.M. Omar Farouque, Jithin Sajeev, Benjamin Cailes, Jay Ramchand, Andrew Teh, Han Lim, Hui-Chen Han, Robert M. Jones, Adam Testro, Mandy Byrne, David Clark, Matias B. Yudi, Paul J. Gow
Journal: Journal of the American College of Cardiology (2019)
Delivery of Bottled Water to Women With Recurrent Urinary Tract Infections: Why in Bulgaria?
Authors: Michael H. Freitag
Journal: JAMA Internal Medicine (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
TRENDS IN RACIAL DIFFERENCES IN 30-DAY READMISSION RATE FOR ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS FROM THE NCDR CHEST PAIN-MI REGISTRY
Authors: Ambarish Pandey, Rohan Khera, Di Lu, Muthiah Vaduganathan, Karen Joynt Maddox, Sandeep Das, Dharam Kumbhani, Abhinav Goyal, Saket Girotra, Paul Chan, Gregg Fonarow, Roland Matsouaka, Tracy Wang, James de Lemos
Journal: Journal of the American College of Cardiology (2019)
COMPARING CARDIOVASCULAR (CV) OUTCOMES IN CANCER SURVIVORS WITH CORONARY ARTERY DISEASE (CAD) VERSUS CAD PATIENTS WITHOUT CANCER HISTORY: ROLE OF WNT PATHWAY AND INFLAMMATION
Authors: Bishesh Shrestha, Kanramon Watthanasuntorn, Benjamin Dao, Charat Thongprayoon, Jennifer Victory, Melissa Scribani, Paul Jenkins, Deborah Hyink, Paul Klotman, Randolph Hutter, Jagdesh Kandala
Journal: Journal of the American College of Cardiology (2019)
Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma
Authors: Wei Li, Liyuan Zhang, Binbin Guo, Jieqiong Deng, Siqi Wu, Fang Li, Yirong Wang, Jiachun Lu, Yifeng Zhou
Journal: Molecular Cancer (2019)

Though esophageal cancer is three to four times more common among males than females worldwide, this type of cancer still ranks in the top incidence among women, even more than the female specific cancer types. The occurrence is currently attributed to extrinsic factors, including tobacco use and alcohol consumption. However, limited attention has been given to gender-specific intrinsic genetic factors, especially in female. We re-annotated a large cohort of microarrays on 179 ESCC patients and identified female-specific differently expressed lncRNAs. The associations between FMR1-AS1 and the risk and prognosis of ESCC were examined in 206 diagnosed patients from eastern China and validated in 188 additional patients from southern China. The effects of FMR1-AS1 on the malignant phenotypes on female ESCC cells were detected in vitro and in vivo. ChIRP-MS, reporter gene assays and EMSA were conducted to identify the interaction and regulation among FMR1-AS1, TLR7 and NFκB. We found FMR1-AS1 expression is exclusively altered and closely associated with the level of sXCI in female ESCC patients, and its overexpression may correlate to poor clinical outcome. ChIRP-MS data indicate that FMR1-AS1 could be packaged into exosomes and released into tumor microenvironment. Functional studies demonstrated that FMR1-AS1 could bind to endosomal toll-like receptor 7 (TLR7) and activate downstream TLR7-NFκB signaling, promoting the c-Myc expression, thus inducing ESCC cell proliferation, anti-apoptosis and invasion ability. Exosome incubation and co-xenograft assay indicate that FMR1-AS1 exosomes may secreted from ESCC CSCs, transferring stemness phenotypes to recipient non-CSCs in tumor microenvironment. Furthermore, we also found a correlation between the serum levels of FMR1-AS1 and the overall survival (OS) of the female ESCC patients. Our results highlighted exosomal FMR1-AS1 in maintaining CSC dynamic interconversion state through the mechanism of activating TLR7-NFκB signaling, upregulating c-Myc level in recipient cells, which may be taken as an attractive target approach for advancing current precision cancer therapeutics in female patients.
DURATION OF DIABETES AND CARDIORENAL EFFICACY OF LIRAGLUTIDE AND SEMAGLUTIDE: A POST HOC ANALYSIS OF THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
Authors: Subodh Verma, Stephen C. Bain, Julie Broe Honore, Tea Monk Fries, Michael A. Nauck, Richard E. Pratley, Soren Rasmussen, Bernard Zinman, John Buse
Journal: Journal of the American College of Cardiology (2019)
INCREMENTAL PREDICTIVE VALUE OF ULTRASOUND EVALUATION OF CAROTID ARTERY IN RISK STRATIFICATION USING MYOCARDIAL PERFUSION IMAGING WITH SEMICONDUCTOR SCANNER
Authors: Yasuyuki Suzuki, Sakura Nagumo, Keiichiro Kuronuma, Rei Matsuo, Tadashi Ashida, Ayano Makita, Shunichi Yoda, Naoya Matsumoto, Yasuo Okumura
Journal: Journal of the American College of Cardiology (2019)
Abstract 15041: Protein Arginine Methyltransferase 5 and Methylosome Protein 50 Suppresses Hypertrophic Responses in Cardiomyocytes by Inhibition of p300/GATA4 Pathway
Authors: Yasufumi Katanasaka, Yukiko Nakagawa, Yoichi Sunagawa, Hiromichi Wada, Akira Shimatsu, Masatoshi Fujita, Koji Hasegawa, Tatsuya Morimoto
Journal: Circulation (2011)

Introduction: One of the intrinsic histone acetyltransferases, p300, serves as a coactivator of hypertrophy-responsive transcriptional factors such as a cardiac zinc finger protein, GATA4, and is i...
IMPACT OF ONSITE CARDIAC SURGICAL COVER ON LONG-TERM OUTCOMES OF PATIENTS WHO UNDERWENT PERCUTANEOUS CORONARY INTERVENTION: FROM SHINANO 5-YEARS REGISTRY
Authors: Chie Nakamura, Soichiro Ebisawa, Takashi Miura, Keisuke Senda, Minami Taki, Masanori Kobayashi, Masahumi Kanai, Yukari Okuma, Takashi Yanagisawa, Naoto Hashizume, Kyuhachi Otagiri, Kyoko Shoin, Noboru Watanabe, Kenichi Karube, Hiroyuki Nakajima, Tatsuya Saigusa, Yusuke Miyashita, Shusaku Maruyama, Hiroaki Tabata, Daisuke Kashiwagi, Ayumu Nagae, Takahiro Sakai, Tamon Kato, Hirohiko Motoki, Koichiro Kuwahara
Journal: Journal of the American College of Cardiology (2019)
RE-INITIATION OF GUIDELINE-DIRECTED CHRONIC CARDIAC MEDICATIONS IS LIMITED POST-DISCHARGE AMONG CARDIAC INTENSIVE CARE SURVIVORS
Authors: Andrea Thompson, Antoinette B. Coe, Michael Sola, Sarah Adie, Fatima Waheedi, Vincent Marshall, Michael Thomas, Theodore J. Iwashyna, Hallie C. Prescott
Journal: Journal of the American College of Cardiology (2019)
MACHINE LEARNING ALGORITHM USING 8 COMMONLY ACQUIRED CLINICAL VARIABLES ACCURATELY PREDICTS MORTALITY IN HEART FAILURE
Authors: Eric Adler, Adriaan Voors, Liviu Klein, Fima Macheret, Iziah Sama, Oscar Braun, Marcus Urey, Wenhong Zhu, Matevz Tadel, Claudio Campagnari, Barry Greenberg, Avi Yagil
Journal: Journal of the American College of Cardiology (2019)
CLINICAL SIGNIFICANCE OF HIP (HIGH INTENSITY PLAQUE) DETECTED BY MRANGIOGRAPHY WITHIN HUMAN ATHEROSCLEROTIC CORONARY ARTERIAL INTIMA: A STUDY WITH INTRAVASCULAR IMAGINGS
Authors: Toshihiko Nishida, Takafumi Hiro, Mitsumasa Sudo, Daisuke Kitano, Daisuke Fukamachi, Michiaki Matsumoto, Koji Oiwa, Yasuo Okumura
Journal: Journal of the American College of Cardiology (2019)
SYSTEMIC LUPUS ERYTHEMATOSUS IS ASSOCIATED WITH INCREASED PERIPROCEDURAL STROKE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION: ANALYSIS OF MOST RECENT NATIONAL INPATIENT SAMPLE, 2016
Authors: Dhrubajyoti Bandyopadhyay, Vivek Modi, Karan Sud, Faris Haddadin, Alba Munoz Estrella, Hassan Beydoun, Adrija Hajra, Rishi Shrivastav, Raktim Ghosh, Eyal Herzog
Journal: Journal of the American College of Cardiology (2019)
FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUSION WITH CARDIOFORM SEPTAL OCCLUDER IN PATIENTS WITH LEFT ATRIAL APPENDAGE RESIDUAL PATENCY OR COMPLEX ANATOMY
Authors: Domenico Giovanni Della Rocca, Rodney Horton, Sanghamitra Mohanty, Chintan Trivedi, Omer Gedikli, Qiong Chen, Alfredo Chauca Tapia, Amin Al-Ahmad, John Burkhardt, G. Gallinghouse, Javier Sanchez, Sharan Sharma, Dhanunjaya Lakkireddy, Luigi Di Biase, Andrea Natale
Journal: Journal of the American College of Cardiology (2019)
LOW RATE OF IMPLEMENTATION OF PREVENTIVE MEDICAL THERAPY FOR NON-OBSTRUCTIVE CORONARY ARTERY DISEASE FOUND ON CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY PERFORMED IN THE EMERGENCY DEPARTMENT
Authors: Sheela Krishnan, Ruth Tamrat, Senthil Selvaraj, Shan Davis, Ashwin Murthy, Dipika Gopal, Mahesh Vidula, Vivek Kulkarni, David Lambert, Daniel Kolansky, Dinesh Jagasia, Victor Ferrari, Frank Silvestry, Srinath Adusumalli
Journal: Journal of the American College of Cardiology (2019)
DIFFERENCE IN MITRAL VALVE MORPHOLOGY BETWEEN ECCENTRIC AND CENTRAL ATRIAL FUNCTIONAL MITRAL REGURGITATION: ITS EFFECT ON PERCUTANEOUS EDGE-TO-EDGE REPAIR
Authors: Jun Yoshida, Takafumi Nagaura, Hiroki Ikenaga, Atsushi Hayashi, Satoshi Yamaguchi, Florian Rader, Robert Siegel, Saibal Kar, Takahiro Shiota
Journal: Journal of the American College of Cardiology (2019)
EFFECT OF ANAKINRA ON COLCHICINE RESISTANT AND STEROID DEPENDENT RECURRENT PERICARDITIS: A SYSTEMIC REVIEW AND META-ANALYSIS
Authors: Muhammad Furqan, Riffat Abdullah, Beni Verma, Chandra Ala, Yasser Sammour, Johnny Chahine, Paul Cremer, Massimo Imazio, Allan Klein
Journal: Journal of the American College of Cardiology (2019)
CURRENT INDICATIONS FOR AND OUTCOMES OF CONCOMITANT TRICUSPID VALVE SURGERY
Authors: Mohanad Hamandi, Robert Smith, William Ryan, Laith Batarseh, Paul Grayburn, Timothy George, Kelly Hutcheson, Katherine Harrington, Justin Schaffer, William Brinkman, Molly Szerlip, David Moore, J. Michael DiMaio, Michael Mack
Journal: Journal of the American College of Cardiology (2019)
CAN WE FOREGO ROUTINE INTENSIVE CARE UNIT (ICU) ADMISSION IN PATIENTS UNDERGOING PRIMARY PCI FOR STEMI? INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM (BMC2)
Authors: Ahmad Abdul-Aziz, Devraj Sukul, Milan Seth, Hitinder Gurm
Journal: Journal of the American College of Cardiology (2019)
OUTCOMES OF PERCUTANEOUS VACUUM-ASSISTED DEBULKING OF LARGE VEGETATIONS AS AN ADJUNCT TO LEAD EXTRACTION
Authors: Soroosh Kiani, Muhie D. Sabayon, Patel V. Akshar, Michael Lloyd, Michael Hoskins, Mikhael El Chami, Stacy Westerman, Rhatna Vadlamudi, William Keeling, Tamir S. Attia, Omar Lattouf, Faisal Merchant
Journal: Journal of the American College of Cardiology (2019)
Applicability and Cost Implications for PCKS9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights from the Department of Veterans Affairs
Authors: Salim S. Virani, Julia M Akeroyd, Vijay Nambi, Erin D. Michos, Pamela B Morris, Khurram Nasir, Sidney C. Smith, Neil J. Stone, Laura A. Petersen, Christie M. Ballantyne
Journal: Circulation (2018)

In the recently presented ODYSSEY Outcomes trial, alirocumab use in patients with acute coronary syndrome (ACS) and LDL-C ≥70mg/dL (or non-HDL-C >100mg/dL or Apo B ≥80mg/dL) resulted in a 15% relative (1.6% absolute) reduction in the risk of major adverse cardiovascular events. We evaluated what proportion of patients in the VA Health Care System would qualify for alirocumab based on ODYSSEY Outcomes criteria, how they are currently treated with LDL-C lowering medications, and the cost implications if other evidence-based medications were utilized first prior to considering a PCSK9 inhibitor.
ROUTINE CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING FOLLOWING PERCUTANEOUS CORONARY INTERVENTIONS
Authors: Mohammed Al-Hijji, Rajiv Gulati, Gregory Barsness, Abdallah El Sabbagh, Jae Yoon Park, Revelee Kaplan, Jeanna L. Feind, Bradley Lewis, Ardaas Kanwar, Thomas Munger, Samuel Asirvatham, Amir Lerman, Mandeep Singh
Journal: Journal of the American College of Cardiology (2019)
CLINICAL IMPACT OF MILD TO MODERATE RENAL FUNCTION IMPAIRMENT AFTER ACUTE PULMONARY EMBOLISM
Authors: Romain Chopard, Guillaume Serzian, Sebastien Humbert, Nicolas Falvo, Mathilde Morel, Benjamin Bonnet, Gabriel Napporn, Elsa Kalbacher, Laurent Obert, Bruno Degano, Gilles Capellier, Yves Cottin, Francois Schiele, Nicolas Meneveau
Journal: Journal of the American College of Cardiology (2019)
NOVEL PREDICTORS OF NEW PERSISTENT LEFT BUNDLE BRANCH BLOCK AND PERMANENT PACEMAKER IMPLANTATION AFTER EVOLUT R TAVR
Authors: Syed Zaid, Miriam Brinkert, Hasan Ahmad, Ryan Kaple, Cenap Undemir, Martin Cohen, Steven Lansman, Asaad Khan, Jason Kovacic, George Dangas, Samin Sharma, Annapoorna Kini, Stefan Toggweiler, Gilbert Tang
Journal: Journal of the American College of Cardiology (2019)
Intraprocedural Imaging of Transcatheter Tricuspid Valve Interventions
Authors: Rebecca T. Hahn, Michael Nabauer, Michel Zuber, Tamim M. Nazif, Jörg Hausleiter, Maurizio Taramasso, Alberto Pozzoli, Isaac George, Susheel Kodali, Vinayak Bapat, Francesco Maisano
Journal: JACC. Cardiovascular imaging (2019)